- Citations, last 5 years
- 392
- Works, last 5 years
- 32
- h-index
- 57
- Scientists listed
- 26
- Grants since 2016
- 95
Grants received
2022–2023 · research · R44
Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2021–2024 · research · R44
A new epigenetic toolbox for inflammation research and drug discovery
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2021–2022 · research · R44
Development of a high-throughput epigenomic mapping platform to molecularly phenotype Crohn's disease
Andrea Lynn Johnstone · EpiCypher (United States) · funded by National Institutes of Health
2021–2022 · research · R43
Development of ultra-efficient antibodies for single cell mapping applications
Bryan J Venters · EpiCypher (United States) · funded by National Institutes of Health
2021–2024 · research · R44
Single-Cell Chromatin Mapping Assays
Bryan J Venters · EpiCypher (United States) · funded by National Institutes of Health
2021–2025 · research · R44
A new epigenetic toolbox for inflammation research and drug discovery
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2021–2023 · research · R44
Single-Cell Chromatin Mapping Assays
Bryan J Venters · EpiCypher (United States) · funded by National Institutes of Health
2021–2024 · research · R44
A new epigenetic toolbox for inflammation research and drug discovery
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2020–2021 · research · R44
Development of efficient quantitative chromatin profiling in kit and high-throughput formats
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2020–2023 · research · R44
Development of efficient quantitative chromatin profiling in kit and high-throughput formats
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2020–2023 · research · R44
Multiplex nucleosome-based profiling for the development of next-generation chromatin labeling reagents
Zu-Wen Sun · EpiCypher (United States) · funded by National Institutes of Health
2020–2024 · research · R44
Development of efficient quantitative chromatin profiling in kit and high-throughput formats
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2020–2022 · research · R44
Multiplex nucleosome-based profiling for the development of next-generation chromatin labeling reagents
Zu-Wen Sun · EpiCypher (United States) · funded by National Institutes of Health
2019–2023 · research · R44
Quantitative mapping of combinatorial histone modifications
Jonathan Michael Burg · EpiCypher (United States) · funded by National Institutes of Health
2019–2025 · research · R44
Quantification of combinatorial epigenetic modifications using defined nucleosome standards
Andrea Lynn Johnstone · EpiCypher (United States) · funded by National Institutes of Health
2019–2022 · research · R44
Development of novel spike-in controls for quantitative chromatin-associated protein profiling
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2019–2020 · research · R44
Development of novel spike-in controls for quantitative chromatin-associated protein profiling
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2019–2022 · research · R44
Quantitative and highly versatile chromatin accessibility platform
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2019–2020 · research · R43
Quantitative mapping of combinatorial histone modifications
Jonathan Michael Burg · EpiCypher (United States) · funded by National Institutes of Health
2019–2021 · research · R44
Quantitative and highly versatile chromatin accessibility platform
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2019–2022 · research · R43
Quantitative assessment of response to epigenetic-targeted therapy
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2019–2021 · research · R43
Development of highly specific and renewable chromatin labelling reagents
Andrea Lynn Johnstone · EpiCypher (United States) · funded by National Institutes of Health
2019–2024 · research · R44
Quantification of combinatorial epigenetic modifications using defined nucleosome standards
Andrea Lynn Johnstone · EpiCypher (United States) · funded by National Institutes of Health
2019–2020 · research · R43
Quantification of combinatorial epigenetic modifications using defined nucleosome standards
Andrea Lynn Johnstone · EpiCypher (United States) · funded by National Institutes of Health
2019–2023 · research · R44
Development of novel spike-in controls for quantitative chromatin-associated protein profiling
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2019–2024 · research · R44
Quantitative mapping of combinatorial histone modifications
Jonathan Michael Burg · EpiCypher (United States) · funded by National Institutes of Health
2018–2020 · research · R43
Aptamer Beacons For High-Throughput Assay Development
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2018–2023 · research · R44
Rapid quantification of nuclear citrullination in human neutrophils
Andrea Lynn Johnstone · EpiCypher (United States) · funded by National Institutes of Health
2018–2023 · research · R44
Rapid quantification of nuclear citrullination in human neutrophils
Andrea Lynn Johnstone · EpiCypher (United States) · funded by National Institutes of Health
2018–2020 · research · R43
Rapid Quantification of Nuclear Citrullination in Human Neutrophils
Andrea Lynn Johnstone · EpiCypher (United States) · funded by National Institutes of Health
2018–2020 · research · R41
Quantifying NETosis via Automated High Content Imaging Convolutional Neural Networks
Laila Elsherif · EpiCypher (United States) · funded by National Institutes of Health
2018–2019 · research · R41
Chemical Libraries Targeting Epigenetic Methyl Writers and Erasers
Andrea Lynn Johnstone · EpiCypher (United States) · funded by National Institutes of Health
2018–2023 · research · R44
Rapid quantification of nuclear citrullination in human neutrophils
Andrea Lynn Johnstone · EpiCypher (United States) · funded by National Institutes of Health
2018–2019 · research · R43
High-Density Modified Histone Peptide Arrays for Tracking Patient Response
Andrea Lynn Johnstone · EpiCypher (United States) · funded by National Institutes of Health
2018–2020 · research · R43
Asymmetric modification of nucleosomes for targeted drug discovery
Zu-Wen Sun · EpiCypher (United States) · funded by National Institutes of Health
2017–2018 · research · R43
Novel enzyme inhibitor screening platform using modified designer nucleosomes
Zu-Wen Sun · EpiCypher (United States) · funded by National Institutes of Health
2017–2022 · research · R44
Novel enzyme inhibitor screening platform using modified designer nucleosomes
Zu-Wen Sun · EpiCypher (United States) · funded by National Institutes of Health
2017–2021 · research · R44
A nucleosome sliding assay platform to screen inhibitors of SWI/SNF chromatin remodeling complexes
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2017–2021 · research · R44
Novel enzyme inhibitor screening platform using modified designer nucleosomes
Zu-Wen Sun · EpiCypher (United States) · funded by National Institutes of Health
2017–2018 · research · R43
A nucleosome sliding assay platform to screen inhibitors of SWI/SNF chromatin remodeling complexes
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health